 Thomas Schroeppel
Concepts (420)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds and Injuries | 34 | 2025 | 711 | 6.080 |
Why?
| | Trauma Centers | 38 | 2025 | 402 | 4.210 |
Why?
| | Brain Injuries | 9 | 2023 | 468 | 3.070 |
Why?
| | Injury Severity Score | 42 | 2025 | 509 | 3.050 |
Why?
| | Rib Fractures | 4 | 2024 | 32 | 2.820 |
Why?
| | Wounds, Nonpenetrating | 14 | 2024 | 273 | 2.500 |
Why?
| | Retrospective Studies | 69 | 2025 | 14518 | 1.910 |
Why?
| | Brain Injuries, Traumatic | 10 | 2023 | 341 | 1.810 |
Why?
| | Hospital Mortality | 15 | 2024 | 850 | 1.640 |
Why?
| | Abdominal Injuries | 10 | 2023 | 118 | 1.580 |
Why?
| | Length of Stay | 20 | 2024 | 1127 | 1.550 |
Why?
| | Thoracic Injuries | 6 | 2024 | 55 | 1.510 |
Why?
| | Trauma Severity Indices | 6 | 2022 | 104 | 1.500 |
Why?
| | Triage | 6 | 2024 | 206 | 1.410 |
Why?
| | Intracranial Hemorrhage, Traumatic | 2 | 2020 | 8 | 1.390 |
Why?
| | Glasgow Coma Scale | 14 | 2024 | 167 | 1.380 |
Why?
| | Practice Guidelines as Topic | 6 | 2024 | 1501 | 1.340 |
Why?
| | Anticoagulants | 8 | 2024 | 637 | 1.290 |
Why?
| | Adrenergic beta-Antagonists | 5 | 2018 | 321 | 1.290 |
Why?
| | General Surgery | 7 | 2022 | 152 | 1.280 |
Why?
| | Adult | 79 | 2025 | 35576 | 1.190 |
Why?
| | Hemothorax | 4 | 2024 | 11 | 1.160 |
Why?
| | Chest Tubes | 3 | 2024 | 29 | 1.120 |
Why?
| | Warfarin | 4 | 2024 | 147 | 1.090 |
Why?
| | Thoracostomy | 2 | 2024 | 17 | 1.080 |
Why?
| | Appendicitis | 3 | 2020 | 125 | 1.020 |
Why?
| | Tomography, X-Ray Computed | 11 | 2024 | 2535 | 1.010 |
Why?
| | Humans | 126 | 2025 | 129650 | 1.010 |
Why?
| | Wounds, Penetrating | 6 | 2021 | 63 | 0.990 |
Why?
| | Cholecystitis, Acute | 5 | 2024 | 23 | 0.990 |
Why?
| | Aged | 50 | 2025 | 22103 | 0.990 |
Why?
| | Female | 96 | 2025 | 68776 | 0.970 |
Why?
| | Male | 93 | 2025 | 63681 | 0.950 |
Why?
| | Stroke | 4 | 2023 | 1071 | 0.940 |
Why?
| | Middle Aged | 64 | 2025 | 31154 | 0.940 |
Why?
| | Subarachnoid Hemorrhage, Traumatic | 1 | 2024 | 2 | 0.930 |
Why?
| | Primary Dysautonomias | 2 | 2014 | 2 | 0.910 |
Why?
| | Pneumothorax | 2 | 2024 | 38 | 0.900 |
Why?
| | Propranolol | 2 | 2014 | 50 | 0.890 |
Why?
| | Frailty | 2 | 2024 | 153 | 0.880 |
Why?
| | Embolization, Therapeutic | 5 | 2024 | 207 | 0.880 |
Why?
| | Venous Thromboembolism | 3 | 2023 | 284 | 0.860 |
Why?
| | Intensive Care Units | 12 | 2021 | 738 | 0.850 |
Why?
| | Postpartum Hemorrhage | 1 | 2023 | 16 | 0.850 |
Why?
| | Vital Capacity | 2 | 2021 | 291 | 0.840 |
Why?
| | Platelet Aggregation Inhibitors | 3 | 2024 | 442 | 0.820 |
Why?
| | Contusions | 1 | 2023 | 20 | 0.820 |
Why?
| | Time-to-Treatment | 2 | 2021 | 180 | 0.820 |
Why?
| | Critical Care | 5 | 2023 | 553 | 0.810 |
Why?
| | Resuscitation | 7 | 2024 | 237 | 0.790 |
Why?
| | Telemetry | 1 | 2022 | 39 | 0.790 |
Why?
| | Syncope | 1 | 2022 | 51 | 0.770 |
Why?
| | Hospitalization | 7 | 2023 | 2070 | 0.750 |
Why?
| | Decompressive Craniectomy | 2 | 2018 | 8 | 0.750 |
Why?
| | Transfusion Reaction | 1 | 2021 | 43 | 0.740 |
Why?
| | Advance Directives | 1 | 2022 | 77 | 0.720 |
Why?
| | Laparotomy | 7 | 2023 | 106 | 0.720 |
Why?
| | Appendix | 2 | 2018 | 27 | 0.700 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 222 | 0.690 |
Why?
| | Craniocerebral Trauma | 1 | 2022 | 152 | 0.680 |
Why?
| | Surgeons | 2 | 2023 | 261 | 0.670 |
Why?
| | Recovery of Function | 4 | 2020 | 642 | 0.670 |
Why?
| | Blood Transfusion | 7 | 2023 | 296 | 0.670 |
Why?
| | Patient Admission | 1 | 2021 | 182 | 0.640 |
Why?
| | Prospective Studies | 31 | 2024 | 7133 | 0.630 |
Why?
| | Internship and Residency | 3 | 2015 | 1053 | 0.630 |
Why?
| | Cholecystectomy, Laparoscopic | 3 | 2023 | 51 | 0.620 |
Why?
| | Laparoscopy | 5 | 2022 | 451 | 0.620 |
Why?
| | Duodenum | 2 | 2016 | 75 | 0.620 |
Why?
| | Propofol Infusion Syndrome | 1 | 2018 | 1 | 0.610 |
Why?
| | Choledocholithiasis | 3 | 2019 | 14 | 0.590 |
Why?
| | Blood Component Transfusion | 4 | 2024 | 82 | 0.580 |
Why?
| | Disease Management | 3 | 2018 | 589 | 0.560 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 303 | 0.560 |
Why?
| | Liver | 7 | 2024 | 1839 | 0.560 |
Why?
| | Wounds, Gunshot | 6 | 2023 | 213 | 0.560 |
Why?
| | Hemorrhage | 6 | 2023 | 678 | 0.550 |
Why?
| | Treatment Outcome | 30 | 2024 | 10230 | 0.550 |
Why?
| | Workload | 3 | 2020 | 153 | 0.550 |
Why?
| | Head Injuries, Closed | 3 | 2016 | 50 | 0.550 |
Why?
| | Risk Assessment | 14 | 2025 | 3240 | 0.510 |
Why?
| | Atrial Fibrillation | 1 | 2020 | 376 | 0.500 |
Why?
| | Sutures | 1 | 2016 | 53 | 0.500 |
Why?
| | Pneumonia, Ventilator-Associated | 5 | 2015 | 49 | 0.500 |
Why?
| | Suture Techniques | 1 | 2016 | 118 | 0.480 |
Why?
| | Critical Illness | 5 | 2018 | 758 | 0.470 |
Why?
| | Emergency Medical Services | 6 | 2022 | 522 | 0.460 |
Why?
| | Cholecystectomy | 4 | 2024 | 59 | 0.460 |
Why?
| | Survival Rate | 7 | 2021 | 1877 | 0.450 |
Why?
| | Efficiency, Organizational | 1 | 2015 | 133 | 0.450 |
Why?
| | United States | 24 | 2025 | 13903 | 0.450 |
Why?
| | Prognosis | 9 | 2022 | 3794 | 0.440 |
Why?
| | Forecasting | 1 | 2016 | 359 | 0.440 |
Why?
| | Emergencies | 4 | 2024 | 155 | 0.430 |
Why?
| | Geriatric Assessment | 3 | 2024 | 205 | 0.420 |
Why?
| | Logistic Models | 10 | 2024 | 1988 | 0.420 |
Why?
| | Anesthetics, Intravenous | 1 | 2013 | 44 | 0.420 |
Why?
| | Nursing Assessment | 1 | 2013 | 53 | 0.420 |
Why?
| | Cholecystitis | 2 | 2023 | 23 | 0.410 |
Why?
| | Aged, 80 and over | 15 | 2025 | 7086 | 0.410 |
Why?
| | Brain Concussion | 1 | 2020 | 548 | 0.400 |
Why?
| | Propofol | 1 | 2013 | 60 | 0.400 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2021 | 206 | 0.400 |
Why?
| | Erythrocyte Transfusion | 4 | 2024 | 181 | 0.400 |
Why?
| | Tennessee | 5 | 2016 | 43 | 0.400 |
Why?
| | Young Adult | 17 | 2021 | 12426 | 0.390 |
Why?
| | Anti-Bacterial Agents | 9 | 2022 | 1717 | 0.380 |
Why?
| | Emergency Service, Hospital | 7 | 2023 | 1902 | 0.380 |
Why?
| | Severity of Illness Index | 6 | 2024 | 2742 | 0.360 |
Why?
| | Firearms | 4 | 2025 | 359 | 0.330 |
Why?
| | Respiration, Artificial | 3 | 2022 | 613 | 0.320 |
Why?
| | Neuroprotective Agents | 1 | 2010 | 122 | 0.320 |
Why?
| | Fibrinolytic Agents | 2 | 2022 | 263 | 0.320 |
Why?
| | Follow-Up Studies | 8 | 2020 | 4897 | 0.310 |
Why?
| | Quality Improvement | 1 | 2017 | 1103 | 0.310 |
Why?
| | Algorithms | 4 | 2021 | 1622 | 0.310 |
Why?
| | Postoperative Complications | 8 | 2021 | 2483 | 0.310 |
Why?
| | Emergency Treatment | 2 | 2020 | 113 | 0.300 |
Why?
| | Carbon Dioxide | 2 | 2022 | 260 | 0.300 |
Why?
| | Time Factors | 7 | 2020 | 6556 | 0.290 |
Why?
| | Medical Errors | 1 | 2009 | 104 | 0.290 |
Why?
| | Cohort Studies | 8 | 2023 | 5420 | 0.290 |
Why?
| | Clinical Protocols | 2 | 2019 | 255 | 0.280 |
Why?
| | Hospital Charges | 1 | 2007 | 41 | 0.270 |
Why?
| | Risk Factors | 9 | 2025 | 9765 | 0.270 |
Why?
| | Hepatic Artery | 2 | 2024 | 59 | 0.270 |
Why?
| | Predictive Value of Tests | 6 | 2024 | 1952 | 0.270 |
Why?
| | Seasons | 1 | 2009 | 502 | 0.270 |
Why?
| | Pregnancy, Tubal | 1 | 2006 | 5 | 0.260 |
Why?
| | Abdomen, Acute | 1 | 2006 | 18 | 0.260 |
Why?
| | Hemoperitoneum | 1 | 2006 | 14 | 0.260 |
Why?
| | Regression Analysis | 3 | 2021 | 993 | 0.260 |
Why?
| | Cervical Vertebrae | 2 | 2019 | 133 | 0.250 |
Why?
| | Appendectomy | 2 | 2020 | 76 | 0.250 |
Why?
| | Fallopian Tubes | 1 | 2006 | 31 | 0.250 |
Why?
| | Frail Elderly | 2 | 2024 | 121 | 0.250 |
Why?
| | Colorado | 5 | 2022 | 4421 | 0.250 |
Why?
| | Registries | 7 | 2021 | 1896 | 0.240 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2005 | 27 | 0.240 |
Why?
| | Superior Mesenteric Artery Syndrome | 1 | 2005 | 6 | 0.240 |
Why?
| | Shock, Hemorrhagic | 2 | 2019 | 165 | 0.240 |
Why?
| | Administration, Oral | 3 | 2024 | 786 | 0.240 |
Why?
| | Adolescent | 21 | 2024 | 20393 | 0.230 |
Why?
| | Plasma | 2 | 2024 | 206 | 0.230 |
Why?
| | Analgesics, Opioid | 2 | 2024 | 913 | 0.230 |
Why?
| | Incidence | 9 | 2020 | 2644 | 0.230 |
Why?
| | Patient Readmission | 2 | 2020 | 667 | 0.220 |
Why?
| | Multivariate Analysis | 6 | 2020 | 1502 | 0.220 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2024 | 18 | 0.220 |
Why?
| | Abdominal Cavity | 1 | 2023 | 5 | 0.220 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2014 | 2012 | 0.220 |
Why?
| | Linear Models | 2 | 2021 | 819 | 0.220 |
Why?
| | Abdomen | 4 | 2023 | 118 | 0.220 |
Why?
| | Abdominal Abscess | 1 | 2023 | 26 | 0.220 |
Why?
| | Anastomosis, Surgical | 3 | 2023 | 149 | 0.210 |
Why?
| | Gastric Bypass | 1 | 2005 | 107 | 0.210 |
Why?
| | Spleen | 3 | 2012 | 507 | 0.210 |
Why?
| | Treatment Failure | 1 | 2024 | 340 | 0.210 |
Why?
| | Leg Injuries | 1 | 2023 | 28 | 0.210 |
Why?
| | Venous Thrombosis | 1 | 2025 | 176 | 0.210 |
Why?
| | Cerebrovascular Trauma | 1 | 2023 | 17 | 0.200 |
Why?
| | Intracranial Hemorrhages | 1 | 2023 | 80 | 0.200 |
Why?
| | Surgical Procedures, Operative | 2 | 2024 | 244 | 0.200 |
Why?
| | Factor Xa Inhibitors | 2 | 2022 | 170 | 0.200 |
Why?
| | Blood Coagulation | 2 | 2023 | 238 | 0.200 |
Why?
| | Equipment Design | 1 | 2024 | 514 | 0.200 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 2 | 2019 | 17 | 0.200 |
Why?
| | Fracture Fixation, Intramedullary | 1 | 2023 | 60 | 0.200 |
Why?
| | Tibial Fractures | 1 | 2023 | 72 | 0.200 |
Why?
| | Intraabdominal Infections | 1 | 2022 | 11 | 0.190 |
Why?
| | Pregnancy | 2 | 2023 | 6402 | 0.190 |
Why?
| | Deamino Arginine Vasopressin | 1 | 2022 | 11 | 0.190 |
Why?
| | Tourniquets | 1 | 2022 | 20 | 0.190 |
Why?
| | Comorbidity | 3 | 2022 | 1547 | 0.180 |
Why?
| | Platelet Transfusion | 1 | 2022 | 59 | 0.180 |
Why?
| | Thrombolytic Therapy | 1 | 2022 | 137 | 0.180 |
Why?
| | Obesity, Morbid | 1 | 2005 | 240 | 0.180 |
Why?
| | Diagnostic Tests, Routine | 1 | 2022 | 102 | 0.180 |
Why?
| | Enoxaparin | 1 | 2021 | 59 | 0.180 |
Why?
| | Diverticulitis, Colonic | 1 | 2020 | 7 | 0.180 |
Why?
| | Coagulants | 1 | 2021 | 15 | 0.180 |
Why?
| | Accidental Falls | 2 | 2020 | 170 | 0.180 |
Why?
| | Extremities | 1 | 2022 | 127 | 0.180 |
Why?
| | Resource Allocation | 1 | 2021 | 39 | 0.180 |
Why?
| | Colorectal Surgery | 1 | 2020 | 22 | 0.180 |
Why?
| | Pneumonia, Bacterial | 2 | 2015 | 115 | 0.180 |
Why?
| | Altitude | 1 | 2025 | 461 | 0.180 |
Why?
| | Wilderness | 1 | 2020 | 16 | 0.170 |
Why?
| | Mountaineering | 1 | 2020 | 34 | 0.170 |
Why?
| | Patient Discharge | 4 | 2022 | 857 | 0.170 |
Why?
| | Colectomy | 1 | 2020 | 94 | 0.170 |
Why?
| | Physician's Role | 1 | 2022 | 206 | 0.170 |
Why?
| | Hypoventilation | 1 | 2019 | 10 | 0.170 |
Why?
| | Cross Infection | 2 | 2015 | 218 | 0.160 |
Why?
| | Omentum | 1 | 2019 | 10 | 0.160 |
Why?
| | Peptic Ulcer Perforation | 1 | 2019 | 4 | 0.160 |
Why?
| | Suicidal Ideation | 1 | 2025 | 463 | 0.160 |
Why?
| | Head Injuries, Penetrating | 1 | 2019 | 5 | 0.160 |
Why?
| | Prisoners | 1 | 2022 | 141 | 0.160 |
Why?
| | Echocardiography | 1 | 2022 | 629 | 0.160 |
Why?
| | Drug Utilization | 1 | 2020 | 171 | 0.160 |
Why?
| | Reproducibility of Results | 4 | 2022 | 3083 | 0.160 |
Why?
| | Skin Diseases, Infectious | 1 | 2019 | 15 | 0.160 |
Why?
| | Wound Infection | 1 | 2019 | 29 | 0.160 |
Why?
| | Herniorrhaphy | 1 | 2019 | 57 | 0.160 |
Why?
| | Age Factors | 4 | 2020 | 3144 | 0.160 |
Why?
| | Postoperative Care | 1 | 2020 | 241 | 0.150 |
Why?
| | Soft Tissue Infections | 1 | 2019 | 35 | 0.150 |
Why?
| | Practice Patterns, Physicians' | 4 | 2020 | 1266 | 0.150 |
Why?
| | Neck Injuries | 1 | 2019 | 21 | 0.150 |
Why?
| | Creatine Kinase | 1 | 2018 | 73 | 0.150 |
Why?
| | Cause of Death | 3 | 2019 | 393 | 0.150 |
Why?
| | Terminal Care | 1 | 2022 | 237 | 0.150 |
Why?
| | Diagnosis, Differential | 4 | 2015 | 1434 | 0.150 |
Why?
| | Survival Analysis | 4 | 2014 | 1274 | 0.150 |
Why?
| | Acute Disease | 3 | 2023 | 980 | 0.150 |
Why?
| | Fractures, Bone | 1 | 2023 | 392 | 0.140 |
Why?
| | Traumatology | 1 | 2018 | 25 | 0.140 |
Why?
| | Organ Size | 1 | 2018 | 447 | 0.140 |
Why?
| | Insurance Coverage | 1 | 2019 | 219 | 0.140 |
Why?
| | Endosonography | 1 | 2019 | 143 | 0.140 |
Why?
| | Surgical Wound Infection | 1 | 2020 | 283 | 0.140 |
Why?
| | Health Care Costs | 1 | 2020 | 367 | 0.140 |
Why?
| | Physical Examination | 1 | 2019 | 234 | 0.140 |
Why?
| | Point-of-Care Testing | 1 | 2017 | 32 | 0.140 |
Why?
| | Mass Screening | 1 | 2025 | 1149 | 0.140 |
Why?
| | Mothers | 1 | 2023 | 729 | 0.140 |
Why?
| | Bronchoalveolar Lavage | 2 | 2015 | 92 | 0.140 |
Why?
| | Renal Dialysis | 1 | 2021 | 423 | 0.130 |
Why?
| | Chi-Square Distribution | 4 | 2012 | 516 | 0.130 |
Why?
| | Lactic Acid | 1 | 2018 | 303 | 0.130 |
Why?
| | Drug Administration Schedule | 2 | 2020 | 769 | 0.130 |
Why?
| | Confidence Intervals | 2 | 2014 | 317 | 0.130 |
Why?
| | Depression | 1 | 2025 | 1307 | 0.130 |
Why?
| | Jejunostomy | 1 | 2015 | 12 | 0.120 |
Why?
| | Enteral Nutrition | 2 | 2015 | 188 | 0.120 |
Why?
| | Vascular System Injuries | 1 | 2016 | 73 | 0.120 |
Why?
| | Respiratory Function Tests | 1 | 2017 | 586 | 0.120 |
Why?
| | Common Bile Duct | 2 | 2023 | 17 | 0.120 |
Why?
| | Monitoring, Physiologic | 3 | 2019 | 268 | 0.120 |
Why?
| | Rehydration Solutions | 1 | 2014 | 8 | 0.120 |
Why?
| | Isotonic Solutions | 1 | 2014 | 37 | 0.120 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2015 | 89 | 0.120 |
Why?
| | Decision Making | 1 | 2022 | 851 | 0.120 |
Why?
| | Spinal Fractures | 1 | 2016 | 81 | 0.120 |
Why?
| | Erythrocyte Indices | 1 | 2014 | 27 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2022 | 752 | 0.110 |
Why?
| | Odds Ratio | 2 | 2014 | 1023 | 0.110 |
Why?
| | Pain | 1 | 2020 | 789 | 0.110 |
Why?
| | Watchful Waiting | 2 | 2024 | 67 | 0.110 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2016 | 198 | 0.110 |
Why?
| | Societies, Medical | 1 | 2018 | 751 | 0.110 |
Why?
| | Child | 9 | 2024 | 20883 | 0.110 |
Why?
| | Athletic Injuries | 1 | 2020 | 511 | 0.110 |
Why?
| | Antibiotic Prophylaxis | 2 | 2019 | 101 | 0.110 |
Why?
| | Ultrasonography | 2 | 2023 | 716 | 0.110 |
Why?
| | Pneumonia, Staphylococcal | 1 | 2013 | 20 | 0.110 |
Why?
| | Hospitals, University | 1 | 2014 | 179 | 0.110 |
Why?
| | Sensitivity and Specificity | 3 | 2019 | 1838 | 0.110 |
Why?
| | Rhabdomyolysis | 1 | 2013 | 22 | 0.100 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 2 | 2013 | 221 | 0.100 |
Why?
| | Nutritional Support | 1 | 2012 | 32 | 0.100 |
Why?
| | Syndrome | 1 | 2013 | 341 | 0.100 |
Why?
| | Statistics, Nonparametric | 4 | 2019 | 422 | 0.100 |
Why?
| | Infusions, Intravenous | 2 | 2010 | 400 | 0.100 |
Why?
| | Acidosis | 1 | 2013 | 89 | 0.100 |
Why?
| | Stents | 1 | 2016 | 504 | 0.100 |
Why?
| | Multiple Trauma | 1 | 2012 | 101 | 0.090 |
Why?
| | Rural Health Services | 1 | 2012 | 111 | 0.090 |
Why?
| | Propensity Score | 2 | 2025 | 265 | 0.090 |
Why?
| | Wounds, Stab | 2 | 2008 | 12 | 0.090 |
Why?
| | Radiography, Thoracic | 2 | 2015 | 168 | 0.090 |
Why?
| | Nitrogen | 1 | 2012 | 167 | 0.090 |
Why?
| | Dietary Proteins | 1 | 2012 | 129 | 0.090 |
Why?
| | Preoperative Care | 2 | 2012 | 340 | 0.090 |
Why?
| | Angiography | 2 | 2024 | 195 | 0.090 |
Why?
| | Operative Time | 2 | 2023 | 124 | 0.090 |
Why?
| | Critical Pathways | 2 | 2009 | 80 | 0.090 |
Why?
| | Arrhythmias, Cardiac | 1 | 2013 | 317 | 0.090 |
Why?
| | Tidal Volume | 2 | 2022 | 84 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2014 | 396 | 0.080 |
Why?
| | Analysis of Variance | 2 | 2012 | 1288 | 0.080 |
Why?
| | Sex Factors | 4 | 2020 | 1968 | 0.080 |
Why?
| | Sigmoidoscopy | 1 | 2009 | 11 | 0.080 |
Why?
| | Digital Rectal Examination | 1 | 2009 | 10 | 0.080 |
Why?
| | Intestinal Fistula | 1 | 2009 | 15 | 0.080 |
Why?
| | Cerebral Angiography | 2 | 2023 | 109 | 0.080 |
Why?
| | Anti-Infective Agents | 1 | 2012 | 248 | 0.080 |
Why?
| | Polytetrafluoroethylene | 1 | 2009 | 24 | 0.080 |
Why?
| | Craniotomy | 1 | 2009 | 69 | 0.080 |
Why?
| | Databases, Factual | 1 | 2014 | 1269 | 0.080 |
Why?
| | Coated Materials, Biocompatible | 1 | 2009 | 59 | 0.080 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2008 | 21 | 0.070 |
Why?
| | Splenic Rupture | 1 | 2008 | 4 | 0.070 |
Why?
| | Intracranial Pressure | 1 | 2008 | 45 | 0.070 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2008 | 71 | 0.070 |
Why?
| | Rectum | 1 | 2009 | 170 | 0.070 |
Why?
| | Surgical Mesh | 1 | 2008 | 46 | 0.070 |
Why?
| | Prosthesis-Related Infections | 1 | 2009 | 75 | 0.070 |
Why?
| | Diaphragm | 1 | 2008 | 43 | 0.070 |
Why?
| | Blood Vessel Prosthesis | 1 | 2009 | 124 | 0.070 |
Why?
| | Wisconsin | 2 | 2022 | 99 | 0.070 |
Why?
| | Diazepam | 1 | 2008 | 34 | 0.070 |
Why?
| | Prevalence | 2 | 2025 | 2564 | 0.070 |
Why?
| | Central Nervous System Depressants | 1 | 2008 | 82 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1201 | 0.070 |
Why?
| | Pseudomonas Infections | 1 | 2009 | 221 | 0.070 |
Why?
| | Hypnotics and Sedatives | 1 | 2008 | 175 | 0.060 |
Why?
| | Exsanguination | 2 | 2019 | 19 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3408 | 0.060 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2008 | 176 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2013 | 790 | 0.060 |
Why?
| | Child, Preschool | 4 | 2024 | 10517 | 0.060 |
Why?
| | Pancreas | 1 | 2007 | 306 | 0.060 |
Why?
| | Calcium | 1 | 2011 | 1213 | 0.060 |
Why?
| | Cost-Benefit Analysis | 1 | 2007 | 569 | 0.060 |
Why?
| | Staphylococcal Infections | 1 | 2009 | 393 | 0.060 |
Why?
| | Radiology, Interventional | 1 | 2024 | 30 | 0.050 |
Why?
| | Hemoglobins | 1 | 2006 | 339 | 0.050 |
Why?
| | Anastomotic Leak | 1 | 2023 | 38 | 0.050 |
Why?
| | Postoperative Hemorrhage | 1 | 2024 | 87 | 0.050 |
Why?
| | Ethanol | 1 | 2008 | 589 | 0.050 |
Why?
| | Patient Acuity | 1 | 2023 | 45 | 0.050 |
Why?
| | Fracture Fixation | 1 | 2023 | 78 | 0.050 |
Why?
| | Morbidity | 1 | 2023 | 302 | 0.050 |
Why?
| | Global Burden of Disease | 1 | 2022 | 18 | 0.050 |
Why?
| | Computed Tomography Angiography | 1 | 2023 | 115 | 0.050 |
Why?
| | Vital Signs | 1 | 2022 | 41 | 0.050 |
Why?
| | Mesentery | 1 | 2021 | 47 | 0.050 |
Why?
| | Contrast Media | 1 | 2024 | 394 | 0.050 |
Why?
| | Alcoholism | 1 | 2008 | 766 | 0.050 |
Why?
| | Energy Intake | 2 | 2015 | 461 | 0.050 |
Why?
| | Bronchoscopy | 2 | 2015 | 216 | 0.050 |
Why?
| | Colon | 1 | 2023 | 254 | 0.040 |
Why?
| | Factor Xa | 1 | 2021 | 32 | 0.040 |
Why?
| | International Classification of Diseases | 1 | 2022 | 122 | 0.040 |
Why?
| | Shock | 1 | 2022 | 92 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 205 | 0.040 |
Why?
| | Blood Coagulation Factors | 1 | 2021 | 53 | 0.040 |
Why?
| | Thoracotomy | 1 | 2020 | 74 | 0.040 |
Why?
| | Chemoprevention | 1 | 2020 | 91 | 0.040 |
Why?
| | Intestines | 1 | 2023 | 348 | 0.040 |
Why?
| | Heart Failure | 1 | 2013 | 2150 | 0.040 |
Why?
| | Kidney | 1 | 2007 | 1385 | 0.040 |
Why?
| | Drainage | 1 | 2020 | 165 | 0.040 |
Why?
| | Blood Gas Analysis | 1 | 2019 | 71 | 0.040 |
Why?
| | Lower Extremity | 1 | 2023 | 404 | 0.040 |
Why?
| | Bilirubin | 1 | 2019 | 96 | 0.040 |
Why?
| | Fasciitis | 1 | 2019 | 12 | 0.040 |
Why?
| | Cellulitis | 1 | 2019 | 48 | 0.040 |
Why?
| | Neck Pain | 1 | 2019 | 27 | 0.040 |
Why?
| | Southwestern United States | 1 | 2019 | 91 | 0.040 |
Why?
| | Needs Assessment | 1 | 2021 | 360 | 0.040 |
Why?
| | Aspirin | 1 | 2022 | 380 | 0.040 |
Why?
| | Abscess | 1 | 2019 | 73 | 0.040 |
Why?
| | Staphylococcus epidermidis | 2 | 2009 | 75 | 0.040 |
Why?
| | Spinal Injuries | 1 | 2019 | 52 | 0.040 |
Why?
| | Observer Variation | 1 | 2019 | 315 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 232 | 0.040 |
Why?
| | Reference Values | 1 | 2019 | 793 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2021 | 1304 | 0.030 |
Why?
| | Pain Management | 1 | 2020 | 327 | 0.030 |
Why?
| | Survivors | 1 | 2020 | 464 | 0.030 |
Why?
| | Canada | 1 | 2018 | 350 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2019 | 857 | 0.030 |
Why?
| | Axillary Artery | 1 | 2016 | 12 | 0.030 |
Why?
| | Brachiocephalic Trunk | 1 | 2016 | 11 | 0.030 |
Why?
| | Infant | 2 | 2020 | 9024 | 0.030 |
Why?
| | Ligation | 1 | 2016 | 87 | 0.030 |
Why?
| | Subclavian Artery | 1 | 2016 | 27 | 0.030 |
Why?
| | Angiography, Digital Subtraction | 1 | 2016 | 43 | 0.030 |
Why?
| | Carotid Artery Injuries | 1 | 2016 | 41 | 0.030 |
Why?
| | Orthotic Devices | 1 | 2016 | 23 | 0.030 |
Why?
| | Unnecessary Procedures | 1 | 2016 | 48 | 0.030 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 759 | 0.030 |
Why?
| | False Negative Reactions | 1 | 2015 | 53 | 0.030 |
Why?
| | Leukopenia | 1 | 2015 | 28 | 0.030 |
Why?
| | Leukocytosis | 1 | 2015 | 32 | 0.030 |
Why?
| | Acid-Base Imbalance | 1 | 2014 | 5 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2015 | 118 | 0.030 |
Why?
| | Pneumonia | 1 | 2020 | 616 | 0.030 |
Why?
| | Parenteral Nutrition | 1 | 2015 | 104 | 0.030 |
Why?
| | Erythrocyte Count | 1 | 2012 | 19 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 5406 | 0.020 |
Why?
| | Nutritional Requirements | 1 | 2012 | 77 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2015 | 868 | 0.020 |
Why?
| | Intraoperative Complications | 1 | 2012 | 131 | 0.020 |
Why?
| | Brain | 1 | 2023 | 2679 | 0.020 |
Why?
| | Sigmoidoscopes | 1 | 2009 | 1 | 0.020 |
Why?
| | Diagnostic Imaging | 1 | 2012 | 334 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2004 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 644 | 0.020 |
Why?
| | Superinfection | 1 | 2009 | 6 | 0.020 |
Why?
| | Aminoglycosides | 1 | 2009 | 23 | 0.020 |
Why?
| | Adhesives | 1 | 2009 | 13 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 5762 | 0.020 |
Why?
| | Minocycline | 1 | 2009 | 27 | 0.020 |
Why?
| | Central Nervous System Bacterial Infections | 1 | 2008 | 5 | 0.020 |
Why?
| | Polyglactin 910 | 1 | 2008 | 6 | 0.020 |
Why?
| | Fasciotomy | 1 | 2008 | 14 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2009 | 197 | 0.020 |
Why?
| | Decompression, Surgical | 1 | 2009 | 99 | 0.020 |
Why?
| | Rifampin | 1 | 2009 | 85 | 0.020 |
Why?
| | Abdominal Wall | 1 | 2008 | 23 | 0.020 |
Why?
| | Hyperplasia | 1 | 2009 | 171 | 0.020 |
Why?
| | Compartment Syndromes | 1 | 2008 | 22 | 0.020 |
Why?
| | Gram-Negative Bacteria | 1 | 2008 | 70 | 0.020 |
Why?
| | Methacrylates | 1 | 2009 | 112 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3973 | 0.020 |
Why?
| | Probability | 1 | 2008 | 306 | 0.020 |
Why?
| | Body Mass Index | 1 | 2015 | 2273 | 0.020 |
Why?
| | Cost Savings | 1 | 2007 | 78 | 0.020 |
Why?
| | ROC Curve | 1 | 2008 | 503 | 0.020 |
Why?
| | Swine | 1 | 2009 | 760 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 1040 | 0.020 |
Why?
| | Continuity of Patient Care | 1 | 2008 | 275 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2009 | 438 | 0.010 |
Why?
| | Pilot Projects | 1 | 2009 | 1587 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4063 | 0.010 |
Why?
| | Animals | 1 | 2009 | 35361 | 0.000 |
Why?
|
|
Schroeppel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|